Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Richard J NowakChristopher S CoffeyJonathan M GoldsteinMazen M DimachkieMichael BenatarJohn T KisselGil I WolfeTed M BurnsMiriam L FreimerSharon NationsVolkan GranitA Gordon SmithDavid P RichmanEmma CiafaloniMuhammad T Al-LoziLaura Ann SamsDianna QuanEroboghene UboguBrenda PearsonAditi SharmaJon W YankeyLiz UribeMichael ShyAnthony A AmatoRobin ConwitKevin C O'ConnorDavid A HaflerMerit E CudkowiczRichard J Barohnnull nullPublished in: Neurology (2021)
ClinicalTrials.gov Identifier: NCT02110706.